These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17473064)

  • 41. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality.
    Williams DL; Ha T; Li C; Kalbfleisch JH; Schweitzer J; Vogt W; Browder IW
    Crit Care Med; 2003 Jun; 31(6):1808-18. PubMed ID: 12794424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells.
    Dalpke AH; Frey M; Morath S; Hartung T; Heeg K
    Immunobiology; 2002 Oct; 206(4):392-407. PubMed ID: 12437070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extensive study of cytokine, chemokines expression in peripheral blood mononuclear cells upon CpG stimulation.
    Peng Y; Zhang L
    J Immunoassay Immunochem; 2015; 36(4):387-97. PubMed ID: 25317864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
    Senn JJ; Burel S; Henry SP
    J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M; Sato M
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of osteoclastogenesis by integrated signals from toll-like receptors.
    Krisher T; Bar-Shavit Z
    J Cell Biochem; 2014 Dec; 115(12):2146-54. PubMed ID: 25079212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation.
    Müller MB; Preil J; Renner U; Zimmermann S; Kresse AE; Stalla GK; Keck ME; Holsboer F; Wurst W
    Endocrinology; 2001 Sep; 142(9):4150-3. PubMed ID: 11517194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
    Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
    Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
    Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toll-like receptor 9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice.
    El Kebir D; Damlaj A; Makhezer N; Filep JG
    Crit Care Med; 2015 Jun; 43(6):e179-89. PubMed ID: 25855902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Vitro and In Vivo Stimulation of Toll-Like Receptor 9 by CpG Oligodeoxynucleotides Incorporated Into Polypod-Like DNA Nanostructures.
    Takahashi Y; Maezawa T; Araie Y; Takahashi Y; Takakura Y; Nishikawa M
    J Pharm Sci; 2017 Sep; 106(9):2457-2462. PubMed ID: 28385547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli.
    Myers LP; Krieg AM; Pruett SB
    Int Immunopharmacol; 2001 Aug; 1(8):1605-14. PubMed ID: 11515823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenal cortical activation in murine colitis.
    Franchimont D; Bouma G; Galon J; Wolkersdörfer GW; Haidan A; Chrousos GP; Bornstein SR
    Gastroenterology; 2000 Dec; 119(6):1560-8. PubMed ID: 11113077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedside.
    Wittig B; Schmidt M; Scheithauer W; Schmoll HJ
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):31-44. PubMed ID: 25577571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection.
    Price P; Olver SD; Silich M; Nador TZ; Yerkovich S; Wilson SG
    Eur J Clin Invest; 1996 Sep; 26(9):811-9. PubMed ID: 8889445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome.
    Weaver LK; Chu N; Behrens EM
    Arthritis Rheumatol; 2019 Jan; 71(1):161-168. PubMed ID: 30073799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity.
    Yang L; Lang Y; Wu H; Xiang K; Wang Y; Yu M; Liu Y; Yang B; He L; Lu G; Ni Q; Chen X; Zhang L
    ACS Nano; 2023 Mar; 17(6):5340-5353. PubMed ID: 36913671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.